Previous 10 | Next 10 |
RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the manageme...
RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Kitakyushu G...
RESEARCH TRIANGLE PARK, N.C., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Kashiwa Kose...
RESEARCH TRIANGLE PARK, N.C., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that GPR Gesundhe...
Medical device company Asensus Surgical ( NYSE: ASXC ) has announced the sale of a Senhance Surgical System to the company's distribution partner in Germany. The digital laparoscopic platform will be placed at an end user oncology focused hospital. For further details see: ...
RESEARCH TRIANGLE PARK, N.C., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that a Senhance ...
RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & ...
Asensus Surgical, Inc. (ASXC) Q3 2022 Results Conference Call November 10, 2022 04:30 PM ET Company Participants Mark Klausner - Investor Relations Anthony Fernando - President and Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conferen...
Asensus Surgical ( NYSE: ASXC ) missed on the top line in its Q3 2022 financial results as revenue of $2.56M was a 0.4% year-over-year decline. Consensus estimate was $2.92M. Net loss in the quarter widened ~18% to $18.9M compared to the prior-year period (-$0.08 per s...
Asensus Surgical press release ( NYSE: ASXC ): Q3 Non-GAAP EPS of -$0.07. Revenue of $2.56M (-0.4% Y/Y). For further details see: Asensus Surgical Non-GAAP EPS of -$0.07, revenue of $2.56M
News, Short Squeeze, Breakout and More Instantly...
Asensus Surgical Inc Com Company Name:
ASXC Stock Symbol:
NYSE Market:
Asensus Surgical Inc Com Website:
RESEARCH TRIANGLE PARK, N.C., July 24, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced that The Rocky Mountain Hospital for Children in Denver, Colorado, part of HCA Healthcare’s Health...
RESEARCH TRIANGLE PARK, N.C., July 23, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDAȁ...
RESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that LKH-Universitätsklinikum Graz in Austria has entered into an agreement ...